Comorbidities and mortality risk factors for patients with bronchiectasis

Area of Science:

• Pulmonary Medicine
• Internal Medicine

Background:

• Comorbidities are prevalent in bronchiectasis patients, negatively impacting quality of life, lung function, and exacerbation frequency.
• Over 13 comorbidities are linked to increased mortality risk in bronchiectasis.
• The heterogeneous and poorly understood relationship between bronchiectasis and comorbidities necessitates further investigation.

Purpose of the Study:

• To explore the diverse biological mechanisms underlying the association between bronchiectasis and its comorbidities.
• To elucidate the causal relationships, shared risk factors, and inflammatory pathways involved.

Main Methods:

• Review of existing literature on bronchiectasis and associated comorbidities.
• Analysis of biological mechanisms including systemic inflammation, airway inflammation, and shared risk factors.
• Examination of specific comorbidity categories: rheumatic disorders, inflammatory bowel diseases, COPD, asthma, and cardiovascular diseases.

Main Results:

• Comorbidities can have a causal relationship with bronchiectasis via systemic inflammation (e.g., rheumatic disorders, IBD).
• Other comorbidities like COPD and asthma share airway inflammation pathways with uncertain cause-effect.
• Shared risk factors, including chronic inflammation and infection, link bronchiectasis to cardiovascular diseases.

Conclusions:

• The relationship between bronchiectasis and comorbidities is complex, involving direct causality, shared inflammatory pathways, and common risk factors.
• Implementing effective management strategies for comorbidities is essential for improving the long-term prognosis of bronchiectasis patients.